Generic Companies with Tentative Approvals for: Msn Labs Pvt Ltd

✉ Email this page to a colleague

Msn Labs Pvt Ltd Generic Filers with Tentative Approvals

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Get Started Free
Applicant	Generic Name	NDA	Strength	Dosage Form
Msn Labs Pvt Ltd	empagliflozin;metformin hydrochloride	212362	25MG/1000MG	TABLET, EXTENDED RELEASE; ORAL
Msn Labs Pvt Ltd	brivaracetam	214922	10MG/ML	SOLUTION; ORAL
Msn Labs Pvt Ltd	empagliflozin; linagliptin	212359	10MG; 5MG	TABLET;ORAL
>Applicant	>Generic Name	>NDA	>Strength	>Dosage Form

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.